Article contents
Fecal Carriage of Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella pneumoniae in Patients and Asymptomatic Healthy Individuals
Published online by Cambridge University Press: 02 January 2015
Abstract
Fecal carriage of extended-spectrum β-lactamase (ESBL)-producing organisms was assessed in 272 inpatients, 162 outpatients, and 426 asymptomatic healthy individuals. Of 860 stool samples cultured, 152 (17.7%) yielded ESBL-producing organisms. Isolates were recovered from 71 (26.1%) of the inpatients, 25 (15.4%) of the outpatients, and 56 (13.1%) of the healthy individuals. These findings suggest that the community could be a reservoir of ESBL-producing organisms.
- Type
- Concise Communications
- Information
- Copyright
- Copyright © The Society for Healthcare Epidemiology of America 2007
References
1.
Moland, SE, Black, JA, Ourada, J, Reisbig, MD, Hanson, ND, Thomson, KS. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals. Antimicrob Agents Chemother
2002;46:3837–3842.Google Scholar
2.
Bou, G, Cartelle, M, Tomas, M, et al.
Identification and broad dissemination of the CTX-M-14 β-lactamase-lactamase in different Escherichia coli strains in the northwest area of Spain. J Clin Microbiol
2002;40:4030–4036.Google Scholar
3.
Kader, AA, Kumar, A. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J
2005;26:956–959.Google Scholar
4.
National Committee for Clinical Laboratory Standards (NCCLS). Performance Standards for Antimicrobial Susceptibility Testing: 15th Informational Supplement. Wayne, PA: NCCLS; 2005:M100-S15.Google Scholar
5.
Cowan, SF, Steel, KJ. Manual for Identification of Medical Bacteria. 3rd ed. Cambridge: Cambridge University Press, 1993:140–143.Google Scholar
6.
Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. ESBLs conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis
1988;10:867–878.Google Scholar
7.
Daoud, Z, Moubareck, C, Hakime, N, Doucet-Populaire, F. Extended spectrum β- lactamase producing Enterobacteriaceae in Lebanese ICU patients: epidemiology and patterns of resistance. J Gen Appl Microbiol
2006;52:169–178.Google Scholar
8.
Bosi, C, Davin-Regli, A, Bornet, C, Mallea, M, Pages, JM, Bollet, C. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J Clin Microbiol
1999;37:2165–2169.Google Scholar
9.
Colodner, R, Rock, W, Chazan, B, Keller, N, Sakran, W, Raz, R. Risk factors for the development of extended-spectrum β-lactamase producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis
2004;23:163–167.Google Scholar
10.
Lucet, JC, Chevret, S, Deere, DI. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit epidemiology and risk factors for acquisition. Clin Infect Dis
1996;22:430–436.Google Scholar
- 65
- Cited by